Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes Mellitus(T2DM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07139548
What this trial is testing

RAY1225 Versus Semaglutide as Add-on Therapy to Oral Antidiabetic Drugs in Participants With Type 2 Diabetes

Who this might be right for
T2DM
Guangdong Raynovent Biotech Co., Ltd 600
Not applicableLooking for participantsNCT07121504
What this trial is testing

Hybrid Closed-Loop for Perioperative Glycemic Control in T2DM With Parenteral Nutrition

Who this might be right for
Type 2 Diabetes
Second Xiangya Hospital of Central South University 40
Not applicableStudy completedNCT04858321
What this trial is testing

Chronic Passive Heating in Individuals With T2DM

Who this might be right for
Type2 Diabetes
University of Portsmouth 17
Not applicableLooking for participantsNCT07574333
What this trial is testing

Effects of Short and Long Courses of Intermittent Hypoxic-Hyperoxic Training in Patients With Type 2 Diabetes Including Elderly

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)HyperglycemiaMetabolic Syndrome+1 more
National Medical Research Center for Therapy and Preventive Medicine 250
Testing effectiveness (Phase 2)Ended earlyNCT03152552
What this trial is testing

A Dose Finding Study to Assess the Effect of LIK066 Compared to Placebo or Empagliflozin in Patients With Type 2 Diabetes Mellitus and Heart Failure

Who this might be right for
Diabetes Mellitus and Heart Failure
Novartis Pharmaceuticals 125
Not applicableNot Yet RecruitingNCT07325838
What this trial is testing

Digital Self-Management Education and Support for Young Adults With Type 2 Diabetes (DSMESYAT2DM)

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Diabetes-related DistressDiabetes Distress
Recep Turan 72
Testing effectiveness (Phase 2)Study completedNCT03132181
What this trial is testing

Empagliflozin as a Modulator of Systemic Vascular Resistance and Cardiac Output in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus Type 2 (T2DM)
RWTH Aachen University 40
Early research (Phase 1)Study completedNCT00871507
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics (Explores What the Body Does to the Drug), and Pharmacodynamics (Explores What a Drug Does to the Body) of JNJ-38431055 in Volunteers With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 25
Early research (Phase 1)Study completedNCT06279234
What this trial is testing

Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Obesity
Pfizer 50
Early research (Phase 1)Looking for participantsNCT07570992
What this trial is testing

A Research Study to Evaluate the Safety of NNC1679-0001 When Given to Healthy Participants and Participants With T2DM

Who this might be right for
Healthy VolunteersDiabetes Mellitus, Type 2
Novo Nordisk A/S 58
Not applicableStudy completedNCT04203147
What this trial is testing

Home-based Diabetes-Modified Behavioral Activation Treatment for Low Income Seniors With T2DM

Who this might be right for
Type 2 Diabetes
State University of New York at Buffalo 200
Post-approval studies (Phase 4)UnknownNCT04135287
What this trial is testing

Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients

Who this might be right for
Diabetes Mellitus, Type 2
Dasman Diabetes Institute 315
Not applicableActive Not RecruitingNCT06888687
What this trial is testing

Comparison of Dietetics Support With and Without Continuous Glucose Monitoring in Individuals With Type 2 Diabetes.

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Continuous Glucose MeasurementDietary Modification
Australian Catholic University 160
Not applicableLooking for participantsNCT07065721
What this trial is testing

Continuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
San Diego State University 40
Large-scale testing (Phase 3)Study completedNCT01177384
What this trial is testing

Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 380
Not applicableStudy completedNCT07692802
What this trial is testing

Postprandial Glycemic and Physiological Responses to Walking With a Wearable Hip Exoskeleton in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
CHA University 14
Not applicableLooking for participantsNCT07660445
What this trial is testing

Endoscopic Sleeve Gastroplasty Plus Duodenal pulsENDO for Obese T2DM

Who this might be right for
Obesity Type 2 Diabetes Mellitus
Chinese University of Hong Kong 20
Testing effectiveness (Phase 2)Study completedNCT03555994
What this trial is testing

Investigate the Effect of MEDI0382 on Hepatic Glycogen Metabolism in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.

Who this might be right for
Type 2 Diabetes Mellitus
MedImmune LLC 51
Large-scale testing (Phase 3)Study completedNCT02099110
What this trial is testing

Ertugliflozin and Sitagliptin Co-administration Factorial Study (VERTIS FACTORAL, MK-8835-005)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 1,233
Not applicableStudy completedNCT00361946
What this trial is testing

The Role of Amylin and Incretins on Postprandial Metabolisms in Adolescents With Type 2 Diabetes Mellitus (T2DM).

Who this might be right for
Type 2 Diabetes
Baylor College of Medicine 45
Next Page